A prospective, open label, randomized study of efficacy of vitamin A as an add on therapy in the clinical outcome of tuberculosis patients

Authors

  • Sujatha G. Department of Pharmacology, Government Mohan Kumaramangalam Medical College, Salem, Tamil Nadu, India
  • Suguna Bai A. Department of Pharmacology, Government Thiruvannamalai Medical College, Thiruvannamalai, Tamil Nadu, India
  • Preetha N. Department of Pharmacology, Government Mohan Kumaramangalam Medical College, Salem, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20172083

Keywords:

Antioxidants, Tuberculosis, Vitamin A

Abstract

Background: Tuberculosis is the most prevalent infectious disease in the world. India accounts for nearly one fifth of global incidence of tuberculosis. If untreated the disease may be fatal within five years in 50-65 percent of cases. Many decades of research have shown that severe oxidative stress plays a significant role in tuberculosis patients. Moreover, the malnutrition which is commonly present in patient with tuberculosis can add to the impaired anti oxidant capacity. The present study was to investigate the effect of supplementation of vitamin A with standard treatment on the health status of newly diagnosed sputum positive pulmonary tuberculosis patients.

Methods: Phase III, prospective, open, two arm parallel group, outpatient, randomized, active controlled study. Centre of the study was Tuberculosis clinic, Department of Internal medicine, Stanley Medical College Chennai.

Duration of the study was for active drug therapy - 2 months, for follow up period - 4 months and for total period - 6 months.

Results: In our study it was evident that there was a statistically significant improvement in the Karnofsky’s score, body mass index, mid upper arm circumference in the in the vitamin A supplementation group when compared to the control group at the end of 2 months and 6 months. And also, a statistically significant decrease in C.R.P. levels and E.S.R levels were also observed.

Conclusions: This study shows that vitamin A as an add on therapy with regular anti-tuberculosis treatment improves the quality of life and decreases the disease activity in pulmonary tuberculosis patients to a greater extent than with routine standard drug therapy alone.

References

WHO. Weekly epidemiological record, January 2004

Avaialble from: http://www.who.int/wer/en/. Accessed June 15 2014.

Govt. of India, TB India 2006, RNTCP Status Report, DOTS for All - All for DOTS, Ministry of Health and Family Welfare, New Delhi, 2006.

Jack CI, Jackson MJ, Hind CR. Circulating markers of free radical activity in patients with pulmonary tuberculosis. Tuber Lung Dis. 1994;75:132-7.

Grimble RF. Malnutrition and the immune response. Impact of nutrients on cytokine biology in infection. Trans R Soc Trop Med Hyg. 1994;88:615-9.

Nathan CF, Brukner LH, Silverstein SC, Cohn ZA. Extra cellular cytolysis by activated macrophages and granulocytes. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J Exp Med. 1979;149:84-99.

Karyadi E, Schultink W, Nelwan R, Gross R. Poor micronutrient status of active pulmonary tuberculosis patients in indonesia. J Nutr. 2000;130(12):2953-8.

Benjamin Caballero. Modern Nutrition in Health and disease, Lippincott Williams and Wilkins. 10th Edition. Philadelphia; 2014:353.

Mario C, O'Brien. Tuberculosis. Harrison's Principles of Internal Medicine; Volume 2. 17th Edition: McGraw-Hill; 2008:1006-1020.

Hanekom WA, Hussey GD, Hughes ET, Potgeiter S, Yogev R, Check IJ. Plasma soluble CD 30 in childhood tuberculosis: effects of disease severity, nutritional status and vitamin A therapy. Clin Diag Lab Immunol. 1999;6:204-8.

Koyanagi A Kuffo D, Gresely L, Shenkin A, Ceuvas LE. Relationships between serum concentrations of C-reactive protein and micronutrients, in patients with tuberculosis; Ann Trop Med Parasitol. 2004;98(4):391-9.

Downloads

Published

2017-05-23

How to Cite

G., S., A., S. B., & N., P. (2017). A prospective, open label, randomized study of efficacy of vitamin A as an add on therapy in the clinical outcome of tuberculosis patients. International Journal of Basic & Clinical Pharmacology, 6(6), 1333–1337. https://doi.org/10.18203/2319-2003.ijbcp20172083

Issue

Section

Original Research Articles